Skip to main content

UC Davis Comprehensive Cancer Center

Xiaosong Joy Jiang, M.D., Ph.D. View profile as PDF

Xiaosong Joy Jiang

Title:

Associate Adjunct Professor, Gastroenterology and Hepatology

Specialty:

Research on Liver Disease

Additional Phone:

Phone: 916-734-0329
Fax: 916-734-7846

Other Languages:

Cantonese, Chinese (Mandarin)

Education:

M.D., Capital Medical University, Beijing China 1998
M.S., Neurobiology, Hong Kong University of Science and Techolology, Hong Kong China 2003
Ph.D., Nutritional Biology, UC Davis, Davis CA 2012

Internships:

Internal Medicine, Capital Medical University - Chaoyang Hospital, Beijing China 1997

Residency:

Internal Medicine, Peking University - Shougang Hospital, Beijing China 1998

Select Honors and Awards:

Richard C. Woodard Research Award, Internal Medicine , UC Davis, 2013

Select Recent Publications:

Bettaieb, A.*, Jiang, J.X.*, Sasaki, Y., Chao, T.I., Kiss, Z., Chen, X., Tian, J., Katsuyama, M., Yabe-Nishimura, C., Xi, Y., Szyndralewiez, C., Schröder, K., Shah, A., Brandes, R.P., Haj, F.G. and Török, N.J. Hepatocyte NADPH oxidase 4 regulates stress signaling, fibrosis, and insulin sensitivity during development of steatohepatitis in mice. Gastro. pii: S0016-5085(15)00509-0. doi: 10.1053/j.gastro. 2015.04.009. (IF:13.926) (*equal contribution)

Jiang, J.X. And Török, N.J. MLK3 as a regulator of disease progression in NASH. Liver Int. 2014 DOI: 10.1111/liv. 12556.

Jiang, J.X. and Török, N.J. Liver injury and the activation of hepatic myofibroblasts. Curr. Pathobiol. Rep. 2013; 1(3): 215-223.

Jiang, J.X., Chen, X., Fukada, H., Serizawa, N., Devaraj, S., and Török, N.J. Advanced glycation end products induce inflammatory and fibrogenic activity in NASH by modulating the TNFα converting enzyme activity. Hepatol. 2013; 58(4):1339-1348.

Medici, V., Shibata, N., Kharbanda, K.K., LaSalle, J.M., Woods, R., Liu, S., Engelberg, J., Cardiff, R.D., Havel, P.J., Devaraj, S., Török, N.J., Jiang, J.X., Lönnerdal, B., Kim, K., Halsted, C.H. Wilson disease: changes in methionine metabolism and inflammation affect global DNA methylation in early liver disease. Hepatol. 2012;57(2):555-565.

Jung, C.J., Iyengar, S., Blahnik, K.R., Jiang, J.X., Tahimic, C., Török, N.J., de Vere White, R.W., Farnham, P.J., Zern, M. Human ESC Self-renewal Promoting microRNAs Induce Epithelial–Mesenchymal Transition in Hepatocytes by Controlling the PTEN and TGFβ Tumor Suppressor Signaling Pathways. Mol Cancer Res. 2012; 10(7):979-991.

Jiang, J.X., Chen, X., Serizawa, N., Szyndralewiez, C., Page, P., Schröder, K., Brandes, R.P., Devaraj, S., Török, N.J. Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo. Free Radic Biol Med. 2012;53(2):289-296.

Jiang, J.X., Chen, X., Hsu, D., Baghy, K., Serizawa, N., Scott, F., Takada, Y., Takada, Y., Fukada, H., Chen, J., Devaraj, S., Adamson, R., Liu, F.T. and Török, N.J. Galectin-3 modulates phagocytosis-induced stellate cell activation and liver fibrosis in vivo. Am. J. Physiol. Gastrointest. Liver Physio. 2012;302(4): G439-446.

Jung, C.J., Iyengar, S., Blahnik, K.R., Ajuha, T.P., Jiang, J.X., Farnham, P.J., Zern, M. Epigenetic modulation of miR-122 facilitates human embryonic stem cell selfrenewal and hepatocellular carcinoma proliferation. PLoS One 2011;6(11):e27740.

Medici, V., Ali, M., Seo, S., Aoki, C., Rossaro, L., Kim, K., Fuller, W., Vidovszky, T., Smith, W., Jiang, J.X., Maganti, K., Havel, P.J., Kamboj, A., Ramsamooj, R. and Török, N.J. Increased Soluble leptin receptor levels in morbidly obese patients with insulin resistance and nonalcoholic fatty liver disease. Obesity. 2010;18(12):2268-2273.